SSY Group Ltd
Mr. Su Xuejun is an executive director and is responsible for marketing and management functions of Shijiazhuang No.4 Pharma. He joined No.1 Pharma as assistant to factory manager in 1990. And afterwards he served as deputy general manager of a subsidiary of the Shijiazhuang Pharmaceutical Group selling preparations. Since January 2002, Mr. Su acts as deputy general manager of Shijiazhuang No.4 Pharma. Since January 2007, Mr. Su acts as executive director of Shijiazhuang No.4 Pharma and New Orient. Since July 2013, Mr. Su acts as deputy chairman of Shijiazhuang No.4 Pharma. Mr. Su graduated from Hebei Normal University, majoring in biology, with a bachelor's degree. He focuses in the pharmaceutical market development, operations and management. He has extensive understanding and experience in the marketing and the policy in the related industries.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
SSY Group Ltd
SSY Group Limited is an investment holding company principally engaged in the research, development, manufacture and sale of pharmaceutical products. Its products include finished medicines of intravenous infusion solution for hospitals and distributors, bulk pharmaceuticals and medical materials. The Company's subsidiaries include New Orient Investments Pharmaceutical Holding (Hong Kong) Limited, Shijiazhuang No.4 Pharmaceutical Co., Ltd. and Hebei Guolong Pharmaceutical Co., Ltd. Through its subsidiaries, the Company is also engaged in logistics of pharmaceutical products in Mainland China.